When biopharma companies choose a partner to develop and manufacture their biologic, they sometimes run into challenges associated with drug product process development. It’s critical that biopharma companies work with a partner that has the proven expertise to conduct drug product process development on their innovator or biosimilar drugs. In this Q&A, one Catalent Biologics expert shares his expertise with drug product process development challenges, risks and how to mitigate them, the difference between innovator and biosimilar drug product process development, and what to expect from the development and manufacturing partner during the drug product process development phase.

Technology transfer is a challenging and multifaceted endeavor with multiple variables that must be carefully considered. Get insights on ken key considerations for a successful tech transfer process for manufacturing a Download this article to learn more aboutduct, includinSteps towards planning a manufacturing process transfery on overcoming challenges in a process transfer for a sterile diluent.
Download this article to learn more about steps towards planning a manufacturing process transfer, how planning and communication can aide in a successful tech transfer and more!